DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
USDÂ 17,69
0,00%
(0,00) 1D
USDÂ 17,09
arrow_downward
-3,40% (-0,60)todayPre-market
Closed: 6 Okt., 15:40:15 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSKYF...
Mkt. cap
31,91Â mjd
Avg. vol.
2,68Â k
Volume
0,00
52-wk high
USDÂ 29,15
52-wk low
USDÂ 13,85
Beta
-1,13
Shares outstanding
1,86Â mjd
No. of employees
20Â k
Mkt. cap
31,91Â mjd
Avg. vol.
2,68Â k
Volume
0,00
52-wk high
USDÂ 29,15
52-wk low
USDÂ 13,85
Beta
-1,13
Shares outstanding
1,86Â mjd
No. of employees
20Â k
News stories
From web sources and news partners
AD HOC NEWS
·
3 uur gelede
Daiichi Sankyo stock gets Citi Buy rating with JPY 4,700 target
Simply Wall Street
·
23 uur gelede
Cancer Trial Tie Up Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
AD HOC NEWS
·
1 dag gelede
Daiichi Sankyo stock faces setback after I-DXd filing withdrawal
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20,2Â k
Founded28 Sep. 2005
HeadquartersChuo City, Tokio, Japan
Sector-
Websitedaiichisankyo.co.jp